Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiovsis species

Applied and Environmental Microbiology

Volumn 76, Issue 15, 2010, Pages 4969-4976

  Engelhardt, Kerstin ^a   Degnes, Kristin F ^b   Kemmler, Michael ^c   Bredholt, Harald ^a,d   Fjaervik, Espen ^a   Klinkenberg, Geir ^b   Sletta, Håvard ^b   Ellingsen, Trond E ^b   Zotchev, Sergey B ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b SINTEF MATERIALS AND CHEMISTRY   (Norway)

^c BioFocus DPI   (United Kingdom)

^d Axellia Pharmaceuticals   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE COMPOUNDS; ANTI-BACTERIAL ACTIVITY; ANTIFUNGAL COMPOUNDS; BACTERIAL STRAINS; CANDIDA ALBICANS; IN-VITRO; INDICATOR ORGANISMS; MARINE SEDIMENTS; MICRO WELLS; MOLECULAR TAXONOMY; NONRIBOSOMAL PEPTIDE; POLYKETIDES; SECONDARY METABOLITES; STRUCTURE ELUCIDATION; THIOPEPTIDE; THIOPEPTIDE ANTIBIOTICS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

BACTERIA; BACTERIOLOGY; METABOLITES; PEPTIDES; POLYPEPTIDES; SEAWATER; SEDIMENTS; SUBMARINE GEOLOGY;

ANTIBIOTICS;

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACK ANALYSIS; BACTERIUM; BIOACTIVITY; FUNGUS; GROWTH RATE; MARINE SEDIMENT; PEPTIDE; POLYMERASE CHAIN REACTION; SEAWATER; SECONDARY METABOLITE;

ACTINOMYCETALES; ANIMAL; ARTICLE; BACTERIUM; BIOSYNTHESIS; CANDIDA ALBICANS; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; FUNGAL GENE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEDIMENT; SPONGE (PORIFERA); BACTERIA; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ACTINOMYCETALES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CANDIDA ALBICANS; GENES, FUNGAL; GEOLOGIC SEDIMENTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES; PORIFERA; SEQUENCE ANALYSIS, DNA;

ACTINOBACTERIA; ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; NOCARDIOPSIS; POSIBACTERIA;

EID: 77955573389     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00741-10     Document Type: Article

References (45)

1. Bagley, M. C., J. W. Dale, E. A. Merritt, and X. Xiong. 2005. Thiopeptide antibiotics. Chem. Rev. 105:685-714.
2. Bentley, S. D., K. F. Chater, A. M. Cerdeno-Tarraga, G. L. Challis, N. R. Thomson, K. D. James, D. E. Harris, M. A. Quail, H. Kieser, D. Harper, A. Bateman, S. Brown, G. Chandra, C. W. Chen, M. Collins, A. Cronin, A. Fraser, A. Goble, J. Hidalgo, T. Hornsby, S. Howarth, C. H. Huang, T. Kieser, L. Larke, L. Murphy, K. Oliver, S. O'Neil, E. Rabbinowitsch, M. A. Rajandream, K. Rutherford, S. Rutter, K. Seeger, D. Saunders, S. Sharp, R. Squares, S. Squares, K. Taylor, T. Warren, A. Wietzorrek, J. Woodward, B. G. Barrell, J. Parkhill, and D. A. Hopwood. 2002. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417:141-147.
3. Bhat, U. G., M. Halasi, and A. L. Gartel. 2009. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One 4:e5592.
4. Bode, H. B., B. Bethe, R. Hofs, and A. Zeeck. 2002. Big effects from small changes: possible ways to explore nature's chemical diversity. Chembiochem 3:619-627.
5. Boeck, L. D., D. M. Berry, F. P. Mertz, and R. W. Wetzel. 1992. A10255, a complex of novel growth-promoting thiopeptide antibiotics produced by a strain of Streptomyces gardneri. Taxonomy and fermentation studies. J. Antibiot. (Tokyo) 45:1222-1230.
6. Bredholdt, H., O. A. Galatenko, K. Engelhardt, E. Fjaervik, L. P. Terekhova, and S. B. Zotchev. 2007. Rare actinomycete bacteria from the shallow water sediments of the Trondheim Fjord, Norway: isolation, diversity and biological activity. Environ. Microbiol. 9:2756-2764.
7. Bredholt, H., E. Fjaervik, G. Johnsen, and S. B. Zotchev. 2008. Actinomycetes from sediments in the Trondheim Fjord, Norway: diversity and biological activity. Mar. Drugs 6:12-24.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing, 15th information supplement M100S15. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cragg, G. M., P. G. Grothaus, and D. J. Newman. 2009. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 109:3012-3043.
10. Feling, R. H., G. O. Buchanan, T. J. Mincer, C. A. Kaufman, P. R. Jensen, and W. Fenical. 2003. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed. Engl. 42:355-357.
11. Felsenstein, J. 1985. Confidence-limits on phytogenies-an approach using the bootstrap. Evolution 39:783-791.
12. Fenical, W., and P. R. Jensen. 2006. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2:666-673.
13. Fiedler, H. P., C. Bruntner, J. Riedlinger, A. T. Bull, G. Knutsen, M. Goodfellow, A. Jones, L. Maldonado, W. Pathom-aree, W. Beil, K. Schneider, S. Keller, and R. D. Sussmuth. 2008. Proximicin A. B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J. Antibiot. (Tokyo) 61:158-163.
14. Fischbach, M. A., and C. T. Walsh. 2006. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem. Rev. 106:3468-3496.
15. Hashimoto, M., T. Murakami, K. Funahashi, T. Tokunaga, K.-I. Nihei, T. Okuno, T. Kimura, H. Naoki, and H. Himeno. 2006. An RNA polymerase inhibitor, cyclothiazomycin B1, and its isomer. Bioorg. Med. Chem. 14:82598270.
16. Huang, X., and A. Madan. 1999. CAF3: a DNA sequence assembly program. Genome Res. 9:868-877.
17. Jørgensen, H., K. F. Degnes, A. Dikiy, E. Fjaervik, G. Klinkenberg, and S. B. Zotchev. 2010. Insights into the evolution of macrolactam biosynthesis through cloning and comparative analysis of the biosynthetic gene cluster for a novel macrocyclic lactam, ML-449. Appl. Environ. Microbiol. 76:283-293.
18. Jørgensen, H., K. F. Degnes, H. Sletta, E. Fjaervik, A. Dikiy, L. Herflndal, P. Bruheim, G. Klinkenberg, H. Bredholt, G. Nygard, S. O. Doskeland, T. E. Ellingsen, and S. B. Zotchev. 2009. Biosynthesis of macrolactam BE-14106 involves two distinct FKS systems and amino acid processing enzymes for generation of the aminoacyi starter unit. Chem. Biol. 16:1109-1121.
19. Jørgensen, H., E. Fjaervik, S. Hakvag, P. Bruheim, H. Bredholt, G. Klinkenberg, T. E. Ellingsen, and S. B. Zotchev. 2009. Candicidin biosynthesis gene cluster is widely distributed among Streptomyces spp. isolated from the sediments and the neuston layer of the Trondheim Fjord, Norway. Appl. Environ. Microbiol. 75:3296-3303.
20. Kelly, W. L., L. Pan, and C. Li. 2009. Thiostrepton biosynthesis: prototype for a new family of bacteriocins. J. Am. Chem. Soc. 131:4327-4334.
21. Kumar, S., M. Nei, J. Dudley, and K. Tamura. 2008. MEGA: a biologistcentric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 9:299-306.
22. Kwok, J. M.-M., S. S. Myatt, C. M. Marson, R. C. Coombes, D. Constantinidou, and E. W.-F. Lam. 2008. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box Ml expression. Mol. Cancer Ther. 7:2022-2032.
23. Li, C., and W. L. Kelly. 2010. Recent advances in thiopeptide antibiotic biosynthesis. Nat. Prod. Rep. 27:153-164.
24. Liao, R., L. Duan, C. Lei, H. Pan, Y. Ding, Q. Zhang, D. Chen, B. Shen, Y. Yu, and W. Liu. 2009. Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications. Chem. Biol. 16:141-147.
25. Magarvey, N. A., J. M. Keller, V. Bernan, M. Dworkin, and D. H. Sherman. 2004. Isolation and characterization of novel marine-derived actinomycete taxa rieh in bioactive metabolites. Appl. Environ. Microbiol. 70:7520-7529.
26. McConkey, G. A., M. J. Rogers, and T. F. McCutchan. 1997. Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J. Biol. Chem. 272:2046-2049.
27. Mincer, T. J., P. R. Jensen, C. A. Kaufman, and W. Fenical. 2002. Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl. Environ. Microbiol. 68:5005-5011.
28. Moreno, C., J Romero, and R. T. Espejo. 2002. Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus Vibrio. Microbiology 148:1233-1239.
29. Morris, R. P., J. A. Leeds, H. U. Naegeli, L. Oberer, K. Memmen, E. Weber, M. J. LaMarche, C. N. Parker, N. Burrer, S. Esterow, A. E. Hein, E. K. Schmitt, and P. Krastel. 2009. Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu. J. Am. Chem. Soc. 131:5946-5955.
30. Nagai, K., K. Kamigiri, N. Arao, K. Suzumura, Y. Kawano, M. Yamaoka, H. Zhang, M. Watanabe, and K. Suzuki. 2003. YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties. J. Antibiot. (Tokyo) 56:123-128.
31. Newman, D. J., and G. M. Cragg. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70:461-477.
32. Omura, S., H. Ikeda, J. Ishikawa, A. Hanamoto, C. Takahashi, M. Shinose, Y. Takahashi, H. Horikawa, H. Nakazawa, T. Osonoe, H. Kikuchi, T. Shiba, Y. Sakaki, and M. Hattori. 2001. Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc. Natl. Acad. Sci. U. S. A. 98:12215-12220.
33. Payne, D. J., M. N. Gwynn, D. J. Holmes, and D. L. Pompliano. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6:29-40.
34. Peláez, F. 2006. The historical delivery of antibiotics from microbial natural products-can history repeat? Biochem. Pharmacol. 71:981-990.
35. Riedlinger, J., A. Reicke, H. Zahner, B. Krismer, A. T. Bull, L. A. Maldonado, A. C. Ward, M. Goodfellow, B. Bister, D. Bischof, R. D. Sussmuth, and H. P. Fiedler. 2004. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. (Tokyo) 57:271-279.
36. Rogers, M. J., E. Cundliffe, and T. F. McCutchan. 1998. The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite. Antimicrob. Agents Chemother. 42:715-716.
37. Rosendahl, G., and S. Douthwaite. 1994. The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A. Nucleic Acids Res. 22:357-363.
38. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. MoL Biol. Evol. 4:406-425.
39. Sekurova, O., H. Sletta, T. E. Ellingsen, S. Valla, and S. Zotchev. 1999. Molecular cloning and analysis of a pleiotropic regulatory gene locus from the nystatin producer Streptomyces noursei ATCC1 1455. FEMS Microbiol. Lett. 177:297-304.
40. Sheridan, C. 2006. Antibiotics au naturel. Nat. Biotechnol. 24:1494-1496.
41. Spellberg, B., J. H. Powers, E. P. Brass, L. G. Miller, and J. E. Edwards, Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38:1279-1286.
42. Tamura, K., M. Nei, and S. Kumar. 2004. Prospects for inferring very large phytogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U. S. A. 101:11030-11035.
43. Udwary, D. W., L. Zeigler, R. N. Asolkar, V. Singan, A. Lapidus, W. Fenical, P. R. Jensen, and B. S. Moore. 2007. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc. Natl. Acad. Sci. U. S. A. 104:10376-10381.
44. Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697703.
45. Wieland Brown, L. C., M. G. Acker, J. Clardy, C. T. Walsh, and M. A. Fischbach. 2009. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proc. Natl. Acad. Sci. U. S. A. 106:2549-2553.